We're increasing our Eli Lilly price target after another beat-and-raise quarter
The strength of its GLP-1 business suggests the stock still has more room to run.
We're increasing our Eli Lilly price target after another beat-and-raise quarter
Markets Brief gilt-and-policy note (2026-08-05): We're increasing our Eli Lilly price target after another beat-and-raise quarter The strength of its GLP-1 business suggests the stock still has more room to… Primary source: original at CNBC Finance (cnbc.com).
